Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ONCE
Delisted

Spark Therapeutics Stock Price (Quote)

$113.57
+0 (+0%)
At Close: Jan 24, 2020

Range Low Price High Price Comment
30 days $113.57 $113.57 Friday, 24th Jan 2020 ONCE stock ended at $113.57. During the day the stock fluctuated 0% from a day low at $113.57 to a day high of $113.57.
90 days $108.00 $113.90
52 weeks $40.64 $114.20

Historical Spark Therapeutics prices

Date Open High Low Close Volume
Mar 11, 2016 $32.27 $33.91 $32.00 $33.82 233 600
Mar 10, 2016 $32.23 $34.00 $30.75 $31.88 255 100
Mar 09, 2016 $32.99 $33.85 $31.11 $31.93 390 700
Mar 08, 2016 $35.33 $35.50 $31.90 $32.03 517 700
Mar 07, 2016 $34.40 $37.59 $33.74 $35.69 431 600
Mar 04, 2016 $34.39 $37.82 $33.67 $34.53 407 200
Mar 03, 2016 $38.01 $38.31 $33.87 $34.18 366 300
Mar 02, 2016 $33.78 $38.59 $33.31 $38.06 661 400
Mar 01, 2016 $32.31 $33.92 $31.36 $33.87 229 200
Feb 29, 2016 $32.34 $33.38 $31.56 $31.86 218 700
Feb 26, 2016 $32.32 $33.42 $31.15 $32.26 206 300
Feb 25, 2016 $33.09 $33.09 $31.25 $32.00 223 500
Feb 24, 2016 $31.69 $33.37 $29.59 $32.79 320 300
Feb 23, 2016 $33.81 $34.25 $32.07 $32.20 280 800
Feb 22, 2016 $34.74 $35.00 $33.56 $33.92 211 600
Feb 19, 2016 $32.18 $34.26 $31.14 $34.02 230 300
Feb 18, 2016 $33.02 $34.01 $31.73 $32.24 316 900
Feb 17, 2016 $29.79 $33.60 $29.45 $32.69 557 100
Feb 16, 2016 $24.71 $30.00 $24.71 $29.17 463 500
Feb 12, 2016 $25.02 $25.22 $24.10 $24.44 305 800
Feb 11, 2016 $24.00 $25.00 $23.43 $24.71 252 800
Feb 10, 2016 $22.61 $25.66 $21.89 $24.10 255 800
Feb 09, 2016 $22.10 $23.41 $21.20 $22.46 330 000
Feb 08, 2016 $24.76 $24.91 $22.49 $22.64 280 200
Feb 05, 2016 $28.16 $29.47 $25.14 $25.14 276 500
Click to get the best stock tips daily for free!

About Spark Therapeutics

Spark Therapeutics Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company develops SPK-RPE65, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia... ONCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT